CERT Certara, Inc.
$9.27 -7.94%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-7.94%
YTD
-28.30%
P/E
—
P/B
1.32
ROE
-6.7%
Div yield
—
Beta
0.72
Market cap
$1.4B
RSI (14)
58
Next earnings
Nov 2, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$10.07
Close
$9.27
VWAP (n/a)
—
Day high
$10.19
Day low
$9.19
Volume
3.9M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
In-Silico Drug Discovery Market Report Now Available: Capitalize on AI-led R&D disruption as revenue surges from $3.3B to $6B by 2030; benchmark Certara, Insilico Medicine, Isomorphic Labs, Exscientia and BenevolentAI to secure share.
Yahoo Finance · Sep 30
Capitalize on Drug Discovery Informatics: Benchmark Schrödinger, Certara, Dotmatics, Thermo Fisher and BIOVIA to Accelerate R&D ROI and Secure Market Advantage
Yahoo Finance · Sep 22
Capitalize on Biosimulation’s R&D Disruption: Benchmark Certara, Simulations Plus, Dassault Systèmes, Schrödinger and Applied BioMath to Accelerate Drug Pipelines and Secure ROI
Yahoo Finance · Sep 22
Certara (CERT) Slashes Jobs While Doubling Down On Software Growth
Yahoo Finance · Sep 14
Certara (CERT) Q2 2026 Earnings Call Transcript
Yahoo Finance · Aug 5
Certara Q2 Earnings Call Highlights
Yahoo Finance · Aug 4
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Aug 7, 2026 View → 10-Q Aug 4, 2026 View → 8-K Aug 4, 2026 View → 8-K Aug 4, 2026 View → 8-K Jun 17, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell CERT. Try it in the Lab to size a position and see the risk.